EE448 Cost-Utility Analysis of Benralizumab in Severe Eosinophilic Asthma in Panama
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.696
https://www.valueinhealthjournal.com/article/S1098-3015(22)00897-X/fulltext
Section Title :
Section Order :
10622
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00897-X&doi=10.1016/j.jval.2022.04.696